Report date: Apr 30, 2024 Conflict count: 350192 Publisher: Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins Title count: 161 Conflict count: 5838 ========================================================== Created: 2019-11-11 15:54:03.0 ConfID: 5556335 CauseID: 1458035857 OtherID: 1397564051 JT: International Clinical Psychopharmacology MD: Brunello, 18 ,4,191,2003,Noradrenaline in mood and anxiety disorders: basic and clinical studies : DOI: 10.1097/00004850-200307000-00001(Journal) (5556335-N ) DOI: 10.1097/01.yic.0000073880.93678.68(Journal) ========================================================== Created: 2019-11-11 15:54:03.0 ConfID: 5556336 CauseID: 1458035857 OtherID: 1397564051 JT: International Clinical Psychopharmacology MD: Feiger, 18 ,4,203,2003,Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double-blind comparator studies : DOI: 10.1097/00004850-200307000-00002(Journal) (5556336-N ) DOI: 10.1097/01.yic.0000073879.27745.23(Journal) ========================================================== Created: 2019-11-11 15:54:03.0 ConfID: 5556337 CauseID: 1458035857 OtherID: 1397564051 JT: International Clinical Psychopharmacology MD: Lepola, 18 ,4,211,2003,Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care : DOI: 10.1097/00004850-200307000-00003(Journal) (5556337-N ) DOI: 10.1097/01.yic.0000074988.54339.7c(Journal) ========================================================== Created: 2019-11-11 15:54:03.0 ConfID: 5556338 CauseID: 1458035857 OtherID: 1397564051 JT: International Clinical Psychopharmacology MD: Möller, 18 ,4,219,2003,Improving the chance of recovery from the short- and long-term consequences of depression : DOI: 10.1097/00004850-200307000-00004(Journal) (5556338-N ) DOI: 10.1097/01.yic.0000074785.11653.ca(Journal) ========================================================== Created: 2019-11-11 15:54:03.0 ConfID: 5556339 CauseID: 1458035857 OtherID: 1397564051 JT: International Clinical Psychopharmacology MD: Yatham, 18 ,4,227,2003,Risperidone in acute and continuation treatment of mania : DOI: 10.1097/00004850-200307000-00005(Journal) (5556339-N ) DOI: 10.1097/01.yic.0000074990.54339.e3(Journal) ========================================================== Created: 2019-11-11 15:54:03.0 ConfID: 5556340 CauseID: 1458035857 OtherID: 1397564051 JT: International Clinical Psychopharmacology MD: Hamann, 18 ,4,237,2003,Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription database : DOI: 10.1097/00004850-200307000-00006(Journal) (5556340-N ) DOI: 10.1097/01.yic.0000074989.54339.35(Journal) ========================================================== Created: 2019-11-11 15:54:03.0 ConfID: 5556341 CauseID: 1458035857 OtherID: 1397564051 JT: International Clinical Psychopharmacology MD: Grant, 18 ,4,243,2003,Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial : DOI: 10.1097/00004850-200307000-00007(Journal) (5556341-N ) DOI: 10.1097/01.yic.0000073881.93678.21(Journal)